PD-64 - The usefulness of newly long acting insulin as Degludec for 2 years in Japanese Type 1 Diabetes.

MLA

Miyakawa, Takaichi, et al. “PD-64 - The Usefulness of Newly Long Acting Insulin as Degludec for 2 Years in Japanese Type 1 Diabetes.” Diabetes Research & Clinical Practice, vol. 120, Oct. 2016, p. S111. EBSCOhost, https://doi.org/10.1016/S0168-8227(16)31197-4.

APA

Miyakawa, T., Kawagoe, N., Watanabe, Y., Nogawa, M., Yoshimura, H., Hasegawa, M., & Fujii, H. (2016). PD-64 - The usefulness of newly long acting insulin as Degludec for 2 years in Japanese Type 1 Diabetes. Diabetes Research & Clinical Practice, 120, S111. https://doi.org/10.1016/S0168-8227(16)31197-4

Chicago

Miyakawa, Takaichi, Noriaki Kawagoe, Yuko Watanabe, Miyuki Nogawa, Hiroko Yoshimura, Makoto Hasegawa, and Hitomi Fujii. 2016. “PD-64 - The Usefulness of Newly Long Acting Insulin as Degludec for 2 Years in Japanese Type 1 Diabetes.” Diabetes Research & Clinical Practice 120 (October): S111. doi:10.1016/S0168-8227(16)31197-4.